MC2397A1 - Peptide ayant une affinité pour les tumeurs et agent de diagnostic radioactif et agent thérapeutique radioactif contenant ce peptide - Google Patents

Peptide ayant une affinité pour les tumeurs et agent de diagnostic radioactif et agent thérapeutique radioactif contenant ce peptide

Info

Publication number
MC2397A1
MC2397A1 MC2323A MC2323A MC2397A1 MC 2397 A1 MC2397 A1 MC 2397A1 MC 2323 A MC2323 A MC 2323A MC 2323 A MC2323 A MC 2323A MC 2397 A1 MC2397 A1 MC 2397A1
Authority
MC
Monaco
Prior art keywords
amino acid
peptide
radioactive
acid sequence
affinity
Prior art date
Application number
MC2323A
Other languages
English (en)
French (fr)
Inventor
Ikuya Seki
Yoshitoshi Itaya
Yoshifumi Shirakami
Komei Washino
Original Assignee
Nihon Mediphysics Co Ltd
Antisoma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd, Antisoma Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of MC2397A1 publication Critical patent/MC2397A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MC2323A 1994-06-07 1995-11-28 Peptide ayant une affinité pour les tumeurs et agent de diagnostic radioactif et agent thérapeutique radioactif contenant ce peptide MC2397A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14865594 1994-06-07

Publications (1)

Publication Number Publication Date
MC2397A1 true MC2397A1 (fr) 1996-07-26

Family

ID=15457667

Family Applications (1)

Application Number Title Priority Date Filing Date
MC2323A MC2397A1 (fr) 1994-06-07 1995-11-28 Peptide ayant une affinité pour les tumeurs et agent de diagnostic radioactif et agent thérapeutique radioactif contenant ce peptide

Country Status (11)

Country Link
US (1) US5827498A (de)
EP (1) EP0700930B1 (de)
KR (1) KR960000250A (de)
AT (1) ATE175977T1 (de)
AU (1) AU684348B2 (de)
CA (1) CA2151099A1 (de)
DE (1) DE69507408T2 (de)
DK (1) DK0700930T3 (de)
ES (1) ES2138111T3 (de)
MC (1) MC2397A1 (de)
TW (1) TW394777B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2165228A1 (en) * 1994-12-27 1996-06-28 Yoshitoshi Itaya Metal chelate forming peptides and use thereof
ES2804476T3 (es) * 2010-12-14 2021-02-08 Recepta Biopharma S A Péptido antitumoral derivado de una región determinante de complementariedad de un anticuerpo monoclonal humanizado contra el transportador NaPI2B
CN104519898A (zh) 2012-06-06 2015-04-15 国家健康与医学研究院 用于治疗癌症的方法和药物组合物
CN111225679B (zh) * 2017-08-19 2024-03-29 俄亥俄州创新基金会 新型基于肽的癌症显像剂
CN107550864B (zh) * 2017-08-23 2020-12-18 科笛生物医药(上海)有限公司 Eppt多肽-聚乙二醇-磷脂复合膜材料、其制备方法及主动靶向脂质体递药系统和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322678A (en) * 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification
JPH04501719A (ja) * 1988-11-10 1992-03-26 インペリアル・キヤンサー・リサーチ・テクノロジー・リミテツド ポリペプチド
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
DK0570493T3 (da) * 1991-02-08 2000-06-26 Diatide Inc Technetium-99m-mærkede polypeptider til billeddannelse.
GB9108652D0 (en) * 1991-04-23 1991-06-12 Antisoma Ltd Immunoreactive compounds

Also Published As

Publication number Publication date
ES2138111T3 (es) 2000-01-01
US5827498A (en) 1998-10-27
KR960000250A (ko) 1996-01-25
TW394777B (en) 2000-06-21
DE69507408D1 (de) 1999-03-04
DE69507408T2 (de) 2000-05-18
ATE175977T1 (de) 1999-02-15
CA2151099A1 (en) 1995-12-08
AU684348B2 (en) 1997-12-11
EP0700930A1 (de) 1996-03-13
DK0700930T3 (da) 1999-09-13
EP0700930B1 (de) 1999-11-03
AU2049995A (en) 1995-12-14

Similar Documents

Publication Publication Date Title
AU638127B2 (en) A bifunctional dtpa-type ligand
MX9709913A (es) Metaloconstrucciones determinadas estructuralmente y aplicaciones.
DE69401216D1 (de) Antimitotische derivate von binären catharanthus roseus
ES2146213T3 (es) Compuestos de porficeno para terapia fotodinamica.
AU579387B2 (en) New tetrapyrrole therapeutic agents
MX9707430A (es) Complejos radiofarmaceuticos ternarios.
DK197386D0 (da) Terapeutiske praeparater til brug ved fotodiagnose og fototerapi
KR920012108A (ko) 담즙산 유도체, 이의 제조방법 및 약제로서의 이의 용도
PH31414A (en) Method of diagnosing cancer precancerous state, orsusceptibility to other forms of diseases by anal ysis of irf-1 specific rna in biopsy samples.
MX9101999A (es) Agentes complejantes e inmunoreactivos radioactivos de objetivo, utiles en composiciones y metodos de formacion de imagen terapeuticos y de diagnostico.
ATE382630T1 (de) Moleküle, die sich in ausgewählten organen oder geweben in-vivo einfinden
CN86103488A (zh) 一种金属螯合蛋白质配合物的形成方法
MC2397A1 (fr) Peptide ayant une affinité pour les tumeurs et agent de diagnostic radioactif et agent thérapeutique radioactif contenant ce peptide
EP1289571A2 (de) Prochelators von radiometall markierte molekülen
AU2001277488A1 (en) Prochelators of radiometal labeled molecules
BR0011728A (pt) Método de inibir a agregação de proteìna amilóide e imagem de depósitos de amilóide
GR1002903B (el) Πεπτιδιο συγγενες με ογκο και ραδιενεργος διαγνωστικος παραγοντας και ραδιενεργος θεραπευτικος παραγοντας που περιεχει το πεπτιδιο.
ATE143813T1 (de) Reagenz für bilderzeugung und therapie von tumoren
EP0659764B1 (de) Peptide modifiziert durch eine Phosphin Gruppe zur Markierung mit 99mTC und 186-188Re oder paramagnetische Agentien
EP0697884B1 (de) Die vorstufe eines liganden zum einbau in peptide
ATE89567T1 (de) Konjugate von vinblastin und seine derivate, verfahren zur herstellung derselben und diese konjugate enthaltende pharmazeutische zusammensetzungen.
HRP20010154A2 (en) Bifunctional antibodies and their use in targeting anti-tumour agents
RU93048177A (ru) Новые 2-сахаринилметиларилкарбоксилаты, полезные в качестве ингибиторов протеолитических ферментов, и использование указанных соединений и композиция на их основе